Funding profile · Digital sleep care

Sleep Reset

One Form D, filed in 2018 under the company’s former name, and nothing since. The filing reports more money than the round the company announced. Everything after 2018 is either undisclosed or absent from the record.

$12.88MSold and fully closed, the only Form D on record (Nov 2018)
40Investors in that offering, about $321,900 each
$10.0MSeries A as announced, Nov 13, 2018, led by Foundation Capital
0SEC filings of any kind since Nov 14, 2018

Data as of September 22, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
April 2017 Y Combinator Not disclosed Y Combinator Reporting
Oct 2017 Shark Tank, season 9 Ask: $600,000 for 5% at a $12M valuation. Declined a joint offer from two sharks of $300,000 for 10% each None; no deal taken Reporting
2017 Seed $2.5M as reported Nov 2017; $2.8M as reported by VentureBeat and by the founder New Enterprise Associates, FJ Labs, Foundation Capital, Drew Houston, Josh Reeves Two figures reported
Nov 2018 Series A $10.0M announced; $12,876,388 sold per the Form D Led by Foundation Capital Form D + reporting
Nov 2018 Total funding to date $12.5M Company figure given to TechCrunch Company-stated
Mar 2023 Sale of the Simple Habit app and platform to Ingenio Not disclosed Ingenio, backed by Alpine Investors Reporting
2019 to 2026 Any later round No filing, no announcement found Unknown Not found

What the filings show

Simple Habit, Inc. · Form D · filed Nov 14, 2018

First sale
Oct 31, 2018
Offered
$12,876,388 equity
Sold
$12,876,388 · $0 remaining
Investors
40 · average about $321,910
Exemption
Rule 506(b) · no non-accredited investors
Fees
Sales commissions $0 · finders fees $0 · minimum investment accepted $0
Related persons
Yunha Kim (executive officer, director, promoter); Steve Vassallo (director)
Issuer detail
Delaware corporation, incorporated 2016 · industry group given as Other Technology · revenue range declined
Filing
SEC EDGAR, CIK 0001758788

Reading the filings

  1. The filing is larger than the announcement.The company announced a $10.0 million Series A on November 13, 2018 and put total funding at $12.5 million. The Form D filed the next day reports $12,876,388 offered and the same amount sold. The difference is $2,876,388, close to the $2.8 million that VentureBeat and the founder both put on the 2017 seed. The likely reading is that the filing swept in the earlier money or notes converting into it. The filing does not say, and no amendment settles it.
  2. The checks are fund sized.$12,876,388 across 40 investors is about $321,910 each. That fits a lead fund plus a tail of angels rather than a crowd, matching the named cast: Foundation Capital leading, New Enterprise Associates and FJ Labs in the seed, and individual founders from Dropbox and Gusto.
  3. The board on file is two people.Only Yunha Kim and Steve Vassallo appear. Vassallo is the Foundation Capital general partner who was quoted on the Series A. No New Enterprise Associates partner is listed as a director, which suggests the seed did not carry a board seat.
  4. Eight years of silence.No filing of any type has appeared under this CIK since November 14, 2018, and no issuer named Sleep Reset exists in EDGAR. That is not proof no money moved. Companies raising under Section 4(a)(2) file no Form D, and the 2023 Simple Habit sale put cash in on undisclosed terms. It does mean there is no public number after 2018.
  5. The name on the filing never changed.The company says it rebranded to Sleep Reset, Inc. in 2023, and the App Store lists that seller. EDGAR still carries the issuer as Simple Habit, Inc. with no former names recorded. Searching the filing record for Sleep Reset returns nothing.
  6. No public money anywhere.No NIH award, no NSF award, no FDA submission, no registered trial. The entire capital story is private equity capital and subscription revenue.

Commercial signals

Signal Detail Source type
Revenue $155,000 in the month before March 2023, described as a $1.86 million annual run rate, with more than 8,000 people having paid for the app since launch. Company-stated
Price $297 for the eight week program in 2023, after a trial priced at the buyer’s choice of $9, $19 or $29. App Store in-app purchases listed at $229.99 and $299.99 in 2026. Reviewer and listing
Payment rails Sold as an HSA and FSA eligible expense. The site invites out-of-network insurance inquiries rather than naming in-network payers. Company-stated
Scope The 2026 offering extends past coaching to home sleep apnea testing, oral appliance therapy and telehealth visits. Company-stated
Regulatory No FDA clearance. The two cleared competitors are Somryst (K191716, March 2020) and Sleepio, marketed as SleepioRx (K233577, August 2024). Public record
Category comparison Pear Therapeutics, which built Somryst, filed for Chapter 11 in 2023. Somryst sold at auction to Nox Health for $3.9 million, within a $6.05 million total for all Pear assets. Reporting
Evidence One peer reviewed paper, 564 completers, uncontrolled. One company outcomes report covering 2,745 members, which states it is not a clinical trial. Peer reviewed and company

What to watch

  • A Form D under a Sleep Reset entity. One is due within 15 days of the first sale of any Regulation D offering, and none has appeared in eight years.
  • Disclosed revenue after 2023. The only figures on the record are the March 2023 run rate and the member counts in the outcomes report.
  • Any FDA submission tied to the sleep apnea testing and oral appliance lines, which sit closer to regulated claims than coaching does.
  • A controlled trial, the missing piece that would change how this company is valued against the two cleared competitors.

The Sleep Reset story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Pine Park Health: Shared investor: Foundation Capital. A primary care practice that puts clinicians inside senior living communities instead of asking residents to travel out
  • Clinikally: Shared investor: Foundation Capital. A telemedicine platform and online pharmacy for dermatology, hair and wellness care in India, built by a Stanford-trained AI researcher and his mother's dermatology
  • VetPronto: Shared investor: Foundation Capital. A Y Combinator company that sent veterinarians into people’s living rooms in fifteen US metro areas and raised $362,718 from 636 small investors on Wefunder
  • Cair Health: Shared investor: Foundation Capital. A San Francisco startup building a roster of named AI agents, Clark, Ella, Chloe, Dennis, Paige and Eve, to run medical billing end to end

Sources

  1. Public recordForm D, Simple Habit, Inc., accession 0001758788-18-000001SEC EDGAR, CIK 0001758788 · Nov 14, 2018
  2. Public recordEDGAR full text search and company search, no issuer named Sleep ResetSEC · accessed Sep 22, 2026
  3. Public recordFDA 510(k) K191716 (Somryst) and K233577 (Sleepio)FDA · Mar 23, 2020 and Aug 5, 2024
  4. Public recordNIH and NSF award databases, no award to the companyAccessed Sep 22, 2026
  5. IndependentMeditation app Simple Habit raises $10 million Series ATechCrunch, Brian Heater · Nov 13, 2018
  6. IndependentSimple Habit raises $2.5 million for freemium meditation appMobiHealthNews, Jonah Comstock · Nov 5, 2017
  7. IndependentMeditation app Simple Habit sells to wellness marketplace Ingenio, pivots the company to Sleep ResetTechCrunch, Ivan Mehta · Mar 29, 2023
  8. IndependentNox Buys Pear’s Insomnia App for Nearly $4 Million at AuctionSleep Review · May 22, 2023
  9. IndependentI Tried the Sleep Reset App, hands on review with pricingVerywell Mind, Elizabeth Michaelson Monaghan · Aug 29, 2023
  10. CompanySleep Reset: CBT for Insomnia, App Store listing and in-app purchase pricesApple App Store · accessed Sep 22, 2026
  11. CompanySleep Reset Outcomes Report 2026thesleepreset.com · accessed Sep 22, 2026
  12. CompanySleep Reset home page, program scope and payment optionsthesleepreset.com · accessed Sep 22, 2026

Compiled from SEC, FDA, NIH and NSF public records and published reports as of September 22, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date and may not capture later sales. Healthcare Venture Capital Fund holds no position in Sleep Reset. This page is not an offer to sell or a recommendation to buy any security.